Your Article Summary
See Latest ArticlesMelatonin as a potential therapeutic agent in psychiatric illness
Human Psychopharmacology: Clinical and Experimental, 07/01/09
Maldonado MD et al. - The pathogenesis of mental disorders remains ambiguous and neuroinflammation has been proposed as a causative agent. This study considers the potential contributions of melatonin as therapeutic agent in CNS and during neuroinflammation in mental disorders.
Related Articles
Coping Strategies of Hospitalized People with Psychiatric Disabilities in Taiwan
Psychiatric Quarterly, 10/21/09
Relevance Score: 67%
Training in partnership: role of service users with intellectual disability and carers
Psychiatric Bulletin, 11/16/09
Relevance Score: 64%
Parole Revocation Among Prison Inmates With Psychiatric and Substance Use Disorders
Psychiatric Services, 11/05/09
Relevance Score: 64%
Impact of psychiatric and social characteristics on HIV sexual risk behavior in Puerto Rican women with severe mental illness
Social Psychiatry and Psychiatric Epidemiology, 10/30/09
Relevance Score: 64%
The relationship of multiple aspects of stigma and personal contact with someone hospitalized for mental illness, in a nationally representative sample
Social Psychiatry and Psychiatric Epidemiology, 10/20/09
Relevance Score: 64%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Effects of budesonide and formoterol on allergen-induced airway responses, inflammation, and airway remodeling in asthma
Journal of Allergy and Clinical Immunology, 12/08/09
Infected atopic dermatitis lesions contain pharmacologic amounts of lipoteichoic acid
Journal of Allergy and Clinical Immunology, 12/08/09
Comparison of low-dose deferoxamine versus standard-dose deferoxamine for treatment of aluminium overload among haemodialysis patients
Nephrology Dialysis Transplantation, 12/08/09
Today in Psychiatry...keeping you current
Receive free subspecialty "5-minute updates" via email
Magnesium for treatment-resistant depression: A review and hypothesis
Medical Hypotheses, 12/08/09
Suboxone (Buprenorphine/Naloxone) as an Agonist Opioid Treatment in Spain: A Budgetary Impact Analysis
European Addiction Research, 12/08/09
Suxamethonium induced prolonged apnea in a patient receiving electroconvulsive therapy
General Hospital Psychiatry, 12/08/09